Latest filing published 05 Dec 2023 for NKGen Biotech, Inc., €677.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James A. Graf is a declared insider at 5 companies (chief executive); the most frequent names are Velodyne Lidar, Inc., NKGen Biotech, Inc. and Silver Eagle Acquisition Corp. The record holds 50 filings, for trades running from 8 May 2012 to 4 December 2023.
The open-market side counts 14 purchases for €66k alongside 3 sales for €23. Taken together, the purchases exceed the sales by €66k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants. 2023 to date brings 4 purchases and no sales.
A typical purchase (the median) is worth €1,065. On 8 out of 10 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 5 December 2023: an open-market purchase of €1,318, in NKGen Biotech, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations